China's State Food and Drug Administration announced Tuesday that every batch of blood products in the nation will be screened beginning on Jan. 1, 2008. At present, only a portion of blood and biological products are required to be tested, said SFDA spokesperson Yan Jiangying. "In the future, samples from every batch of blood products will be sent to the National Institute for the Control of Pharmaceutical and Biological Products before sale or import. It will take longer to approve the blood products production and sale, but it is worthwhile since people's life safety can be better protected with stricter supervision," Yan said. SFDA will continue sending inspectors to China's 33 blood products manufacturers and 33 vaccine makers to boost supervision of blood and biological products, a process launched on March 31.

www.aegis.org